NASDAQ: NTLA       Intellia Thera CS
Last Price Today's Change   Day's Range   Trading Volume
82.37   -0.93 (1.12%)  82.25 - 92.00  2,206,996


Avg Volume (4 weeks):2,068,355
4 Weeks Range:48.16 - 92.00
4 Weeks Price Volatility (%):
52 Weeks Range:9.18 - 92.00
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Intellia Therapeutics Inc was incorporated in Delaware in May 2014, as AZRN, Inc. In July 2014, the Company changed its name from AZRN, Inc to Interllia Therapeutics Inc. It is a gene editing company focused on the development of proprietary, potentially curative therapeutics utilizing a biological tool known as the CRISPR/Cas9 system. CRISPR/Cas systems include one or more proteins that cleave DNA guided by an RNA guide sequence, pieces of RNA that both recognize specific DNA sequences and activate the cleaving activity of the Cas proteins. The Company's competitors include CRISPR Therapeutics, Inc, Cellectis S.A., Cellectis S.A., and Juno Therapeutics, Inc.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2853  3532  244  3252 

Top 10 Active Counters
 SNDL 0.716+0.025 
 BNGO 8.11+1.16 
 CCIV 18.44+1.08 
 LK 1.38+1.38 
 CTRM 0.335-0.025 
 AMC 2.418+0.238 
 BB 9.84+0.73 
 AVGR 1.528+0.418 
 OBSV 4.17+1.65 
 WPX 9.43+0.48 


1. Equities Retreated on Waning Optimism State of The Markets
2. Daily Futures Trading Strategy 15 January 2021 Where Futures Lies
3. CryptoNews of the Week CryptoNews
4. Markets Mixed on Hedging State of The Markets
5. Impeachment, Stimulus And The Markets Wall Street Breakfast